Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$59.26 - $71.14 $9,303 - $11,168
-157 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$55.72 - $67.12 $8,748 - $10,537
157 New
157 $10,000
Q4 2021

Feb 15, 2022

SELL
$54.02 - $63.83 $8,481 - $10,021
-157 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $6,333 - $6,930
114 Added 265.12%
157 $9,000
Q1 2020

May 18, 2020

BUY
$37.79 - $51.33 $1,624 - $2,207
43 New
43 $2,000
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $1,825 - $2,169
-43 Closed
0 $0
Q2 2018

May 28, 2020

BUY
$34.55 - $37.05 $1,485 - $1,593
43 New
43 $2,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $219B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.